Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin

Digital

• Autores: Ferrannini, Giulia; Gerstein, Hertzel; Colhoun, Helen Martina; Dagenais, Gilles R.; Diaz, Rafael; Dyal, Leanne; Lakshmanan, Mark; Mellbin, Linda; Probstfield, Jeffrey; Riddle, Matthew Casey; Shaw, Jonathan Edward; Avezum, Alvaro; Basile, Jan Neil; Cushman, William C.; Jansky, Petr; Keltai, Mátyás; Lanas, Fernando; Leiter, Lawrence Alan; Lopez-Jaramillo, Patricio; Pais, Prem; Pīrāgs, Valdis; Pogosova, Nana; Raubenheimer, Peter Johann; Huey-Herng Sheu, Wayne; Rydén, Lars
• Tipo de recurso: Article of journal
• Fecha de publicación: 2021
• Institución: Universidad de Santander
• Repositorio: Repositorio Universidad de Santander
• Idioma: eng
• OAI Identifier: oai:repositorio.udes.edu.co:001/6070
• Acceso en línea: https://doi.org/10.1093/eurheartj/ehaa777; https://repositorio.udes.edu.co/handle/001/6070
• Palabra clave: Cardiovascular disease; GLP-1-based therapy; Metformin; Mortality; Morbidity
• Rights: closedAccess
• License: Copyright © The Authors, European Society of Cardiology, 2021